Rituximab Products

Antibodies
Rituximab Antibody (108F11.02 ...
Rituximab Antibody (108F11.02)
DDX5011P-100
Species: Hu
Applications: ELISA
Host: Mouse Monoclonal
Rituximab Antibody (109H9.06) ...
Rituximab Antibody (109H9.06)
DDX5010P-100
Species: Hu
Applications: ELISA
Host: Mouse Monoclonal
Conjugate Catalog # Availability Size Price
Rituximab Antibody (108F11.02 ...
Rituximab Antibody (108F11.02)
DDX5011B-100
Species: Hu
Applications: WB
Host: Mouse Monoclonal

Description

Rituximab humanised monoclonal antibody is a therapeutic reagent directed against the human CD20 cell surface antigen. Rituximab is a therapeutic reagent directed against the human CD20 cell surface antigen. This antibody has been used to detect Rituximab bound to the surface of the Raji B cell line, however detection of Rituximab bound 'in vivo' to B CLL cells has not been demonstrated. It is possible that complement deposition on Rituximab opsonised cells inhibits binding of the anti-Rituximab antibody to cell bound Rituximab.

Bioinformatics

Alternate Names
  • B lymphocyte antigen CD20
  • MS4A1
  • Membrane spanning 4 domains subfamily A member 1
  • LEU16
  • LEU 16
  • CD20
  • Bp35
  • B lymphocyte surface antigen B1
  • B lymphocyte antigen CD20
  • MS4A1
  • Membrane spanning 4 domains subfamily A member 1
  • LEU16
  • LEU 16
  • CD20
  • Bp35
  • B lymphocyte surface antigen B1
  • B lymphocyte antigen CD20
  • MS4A1
  • Membrane spanning 4 domains subfamily A member 1
  • LEU16
  • LEU 16
  • CD20
  • Bp35
  • B lymphocyte surface antigen B1

Research Areas for Rituximab

Find related products by research area and learn more about each of the different research areas below.

Adaptive Immunity
CD Markers
Cell Biology
Cytokine Research
Immunology
Signal Transduction
Stem Cell Markers